Efficiency of aromatase inhibitors in combined therapy for external genital endometriosis

M. I Yarmolinskaya; A. S Molotkov; V. F Bezhenar; I. M Kvetnoi

doi:10.17816/aog35477

V.F.Snegirev Archives of Obstetrics and Gynecology ›› 2014, Vol. 1 ›› Issue (1) : 36 -40. DOI: 10.17816/aog35477

Original study articles

research-article

Efficiency of aromatase inhibitors in combined therapy for external genital endometriosis

Author information +

History +

PDF

Abstract

Aromatase expression in endometrioid heterotopies was studied. The results served as pathogenetic validation of using aromatase inhibitors in combined therapy for genital endometriosis. Aromatase inhibitors were used in the treatment of endometriosis patients. The efficiency of sterility control and painful syndrome arrest were evaluated and the side effects of therapy were characterized.

Keywords

endometriosis / aromatase / combined therapy / aromatase inhibitors

Cite this article

Download citation ▾

M. I Yarmolinskaya, A. S Molotkov, V. F Bezhenar, I. M Kvetnoi. Efficiency of aromatase inhibitors in combined therapy for external genital endometriosis. V.F.Snegirev Archives of Obstetrics and Gynecology, 2014, 1(1): 36-40 DOI:10.17816/aog35477

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Адамян Л.В., Кулаков В.И. Эндометриозы: Руководство для врачей. М.: Медицина; 2006.

[2]	Баскаков В.П., Цвелев Ю.В., Кира Е.Ф. Эндометриоидная болезнь. СПб.: Издательство «Н-Л»; 2002.

[3]	Bulun S.E. Endometriosis: Mechanisms of disease. N. Engl. J. Med. 2009; 360 (3): 268-79.

[4]	Giudice L.C., Evers J.L.H., Healy D.L., eds. Endometriosis: Science and practice. New York; 2012.

[5]	Гинекология от пубертата до постменопаузы: Практическое руководство для врачей / Айламазян Э.К., Потин В.В., Тарасова М.А. и др.; под ред. Э.К. Айламазян. 3-е изд. М.: МЕДпресс-информ; 2007.

[6]	Koninckx P.R., Barlow D., Kennedy S. Implantation versus infiltration: the Sampson versus the endometriotic disease theory. Gynecol. Obstet. Invest. 1999; 47: 3-9.

[7]	Missmer S.A., Hankinson S.E., Spiegelman D., Barbieri R.L., Marshall L.M., Hunter D.J. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am. J. Epidemiol. 2004; 160(8): 784-96.

[8]	Alkatout I., Mettler L., Beteta C., Hedderich J., Jonat W., Schollmeyer T. et al. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J. Minim. Invasive Gynecol. 2013; 13: 75-7.

[9]	Ge C.X., Zhu X.H., Tang X.Q. Efficacy of conservative laparoscopic surgery combined with goserelin in treatment of 206 patients with severe ovarian endometriosis at short-term and long-term follow-up. Zhonghua Fu Chan Ke Za Zhi. 2012; 47 (8): 603-7.

[10]	Romer, T. Treatment of endometriosis. Med. Monatsschr. Pharm. 2012; 35(2): 44-51.

[11]	Schweppe, K.W. Guidelines for the use of GnRH-analogues in the treatment of endometriosis. Zbl. Gynakol. 2005; 127 (5): 308-13.

[12]	Бурлев В.А., Шорохова М.А., Самойлова Т.Е. Современные принципы патогенетического лечения эндометриоза. Consilium Medicum. 2007; 9 (6): 8-12.

[13]	Guo S.W. Recurrence of endometriosis and its control.Hum. Reprod. 2009; 15 (4): 441-61.

[14]	Verma A., Konje J.C. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 143 (2): 112-5.

[15]	Papanikolaou E.G., Polyzos N.P., Humaidan P., Pados G., Bosch E., Tournaye H. et al. Aromatase inhibitors in stimulated IVF cycles. Reprod. Biol. Endocrinol. 2011; 21 (9): 85.